Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Newmont Mining | 2.53% | $474.62M | $134.99B | 189.05% | 81 Outperform | |
| Exxon Mobil | 2.44% | $457.14M | $621.93B | 36.02% | 74 Outperform | |
| Merck & Company | 2.34% | $438.78M | $307.60B | 35.55% | 80 Outperform | |
| Gilead Sciences | 2.33% | $436.79M | $183.17B | 32.38% | 78 Outperform | |
| Chevron | 2.32% | $435.61M | $373.19B | 18.49% | 71 Outperform | |
| Verizon | 2.24% | $421.10M | $210.29B | 14.07% | 81 Outperform | |
| Altria Group | 2.24% | $420.35M | $116.25B | 23.66% | 64 Neutral | |
| Bristol-Myers Squibb | 2.21% | $415.04M | $125.45B | 5.82% | 78 Outperform | |
| Conocophillips | 2.21% | $414.44M | $135.18B | 13.92% | 78 Outperform | |
| Comcast | 2.18% | $409.28M | $113.73B | -11.83% | 74 Outperform |